Sarcopenia in Advanced COPD Affects Cardiometabolic Risk Reduction by Short-Term High-intensity Pulmonary Rehabilitation.

[1]  S. Kritchevsky,et al.  A Multidimensional Risk Score to Predict All-Cause Hospitalization in Community-Dwelling Older Individuals With Obstructive Lung Disease. , 2016, Journal of the American Medical Directors Association.

[2]  A. Schols,et al.  Muscle Quality is More Impaired in Sarcopenic Patients With Chronic Obstructive Pulmonary Disease. , 2016, Journal of the American Medical Directors Association.

[3]  Claire E. Wells,et al.  Insulin resistance is associated with skeletal muscle weakness in COPD , 2016, Respirology.

[4]  N. Ambrosino,et al.  Response to pulmonary rehabilitation: toward personalised programmes? , 2015, European Respiratory Journal.

[5]  S. Gonçalves,et al.  HOMA-IR is associated with significant angiographic coronary artery disease in non-diabetic, non-obese individuals: a cross-sectional study , 2015, Diabetology & Metabolic Syndrome.

[6]  K Khunti,et al.  The effects of high‐intensity interval training on glucose regulation and insulin resistance: a meta‐analysis , 2015, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[7]  E. Wouters,et al.  Differential response to pulmonary rehabilitation in COPD: multidimensional profiling , 2015, European Respiratory Journal.

[8]  M. Rennie,et al.  Obesity Appears to Be Associated With Altered Muscle Protein Synthetic and Breakdown Responses to Increased Nutrient Delivery in Older Men, but Not Reduced Muscle Mass or Contractile Function , 2015, Diabetes.

[9]  E. Wouters,et al.  Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD , 2015, European Respiratory Journal.

[10]  D. Mannino,et al.  Economic Burden of COPD in the Presence of Comorbidities , 2015, Chest.

[11]  S. Yusuf,et al.  The burden of disease in older people and implications for health policy and practice , 2015, The Lancet.

[12]  W. März,et al.  HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients. , 2015, Journal of the American Society of Nephrology : JASN.

[13]  D. Mannino,et al.  Economic Burden of Chronic Obstructive Pulmonary Disease by Presence of Comorbidities , 2015 .

[14]  L. V. van Loon,et al.  Lipid-Induced Insulin Resistance Is Associated With an Impaired Skeletal Muscle Protein Synthetic Response to Amino Acid Ingestion in Healthy Young Men , 2014, Diabetes.

[15]  Eva Županič,et al.  The Effect of 4-week Rehabilitation on Heart Rate Variability and QTc Interval in Patients with Chronic Obstructive Pulmonary Disease , 2014, COPD.

[16]  I. Kema,et al.  Prednisolone increases enterohepatic cycling of bile acids by induction of Asbt and promotes reverse cholesterol transport. , 2014, Journal of hepatology.

[17]  Lihui Zhao,et al.  Coronary Heart Disease Risks Associated with High Levels of HDL Cholesterol , 2014, Journal of the American Heart Association.

[18]  S. Moon.  Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. , 2014, Endocrine journal.

[19]  Thierry Troosters,et al.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. , 2013, American journal of respiratory and critical care medicine.

[20]  A. Dominiczak,et al.  2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. , 2013, Journal of hypertension.

[21]  Martijn A Spruit,et al.  Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[22]  J. Zierath,et al.  Exercise metabolism and the molecular regulation of skeletal muscle adaptation. , 2013, Cell metabolism.

[23]  G. Wesseling,et al.  Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. , 2011, The American journal of clinical nutrition.

[24]  E. Wouters,et al.  Increased postabsorptive and exercise-induced whole-body glucose production in patients with chronic obstructive pulmonary disease. , 2011, Metabolism: clinical and experimental.

[25]  Steven R. Jones,et al.  Advanced chronic obstructive pulmonary disease is associated with high levels of high-density lipoprotein cholesterol. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  J. Cockcroft,et al.  Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? , 2011, BMC pulmonary medicine.

[27]  I. Tkáč,et al.  Metabolic Phenotype and Adipose Tissue Inflammation in Patients with Chronic Obstructive Pulmonary Disease , 2010, Mediators of inflammation.

[28]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[29]  A. Holland,et al.  Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. , 2010, Archives of physical medicine and rehabilitation.

[30]  L. Tamer,et al.  Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease , 2010, Scandinavian journal of clinical and laboratory investigation.

[31]  R. Ross,et al.  Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial. , 2009, Archives of internal medicine.

[32]  D. Coyle,et al.  Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes , 2007, Annals of Internal Medicine.

[33]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[34]  J. Hankinson,et al.  General considerations for lung function testing , 2005, European Respiratory Journal.

[35]  P. Jones.  St. George's Respiratory Questionnaire: MCID , 2005, COPD.

[36]  E. Wouters,et al.  Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. , 2004, Chest.

[37]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[38]  J. Simoneau,et al.  Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. , 1997, Journal of applied physiology.

[39]  A. Klip,et al.  Glucose Transport and Glucose Transporters in Muscle and Their Metabolic Regulation , 1990, Diabetes Care.